Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
AACR 2020
27 - 28 Apr 2020
Virtual Annual Meeting
Atezolizumab as monotherapy or in combination with cobimetinib in biliary tract ...
Dr Mark Yarchoan - John Hopkins Medicine, Baltimore, USA
30 Jul 2020
High mortality among hospital-acquired COVID-19 infection in patients with cance...
Dr Arielle Elkrief - University of Montreal Hospital Research Centre, Montreal, ...
20 Jul 2020
Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with r...
Dr Haneen Shalabi - National Cancer Institute, NIH, Bethesda, USA
30 Jun 2020
COM701 as a monotherapy and in combination with nivolumab for various advanced s...
Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA
27 May 2020
COVID-19: Using oncology drugs and surgery during the coronavirus pandemic
Dr. Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy
21 May 2020
TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patie...
Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA
21 May 2020
IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imp...
Dr Steven O'Day - John Wayne Cancer Institute, Santa Monica, USA
19 May 2020
A first-of-its-kind prospective study of a multi-cancer blood test to screen and...
Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA
13 May 2020
I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER...
Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA
5 May 2020
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients wit...
Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia
1 May 2020
Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated m...
Prof Alain Algazi -University of California San Francisco, San Francisco, USA
30 Apr 2020
